Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy
出版年份 2018 全文链接
标题
Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy
作者
关键词
-
出版物
DIGESTION
Volume 97, Issue 3, Pages 212-218
出版商
S. Karger AG
发表日期
2018-02-01
DOI
10.1159/000485097
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication
- (2017) Soichiro Sue et al. INTERNAL MEDICINE
- Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
- (2017) Kouichi Sakurai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-LineHelicobacter pyloriEradication: A Randomized Controlled Trial
- (2017) Masafumi Maruyama et al. Canadian Journal of Gastroenterology and Hepatology
- Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype
- (2016) T. Kagami et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy
- (2016) Sho Suzuki et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis
- (2016) Yiqiao Xin et al. BMC GASTROENTEROLOGY
- Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan
- (2016) Mitsushige Sugimoto et al. DIGESTION
- Trends in Gastrointestinal Diseases in Japan
- (2016) Yasuhisa Shinomura DIGESTION
- Key Issues Associated with Helicobacter pylori Eradication
- (2016) Takashi Kawai et al. DIGESTION
- A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori
- (2016) Masahiro Tsujimae et al. DIGESTION
- Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study
- (2016) Kazunari Murakami et al. GUT
- Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes
- (2016) Tadayoshi Okimoto et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Vonoprazanversusconventional proton pump inhibitor-based triple therapy as first-line treatment againstHelicobacter pylori: A multicenter retrospective study in clinical practice
- (2016) Satoki Shichijo et al. Journal of Digestive Diseases
- A novel potassium-competitive acid blocker improves the efficacy of clarithromycin-containing 7-day triple therapy against Helicobacter pylori
- (2016) Journal of Gastrointestinal and Liver Diseases
- Comparison of vonoprazan and proton pump inhibitors for eradication of Helicobacter pylori
- (2016) Satoshi Shinozaki et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Analysis of the cost-effectiveness of using vonoprazan–amoxicillin–clarithromycin triple therapy for first-line Helicobacter pylori eradication
- (2016) Yusaku Kajihara et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker
- (2016) Hitomi Yamasaki et al. XENOBIOTICA
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antimicrobial Resistance and Characteristics of Eradication Therapy ofHelicobacter pyloriin Japan: A Multi-Generational Comparison
- (2014) Takuma Okamura et al. HELICOBACTER
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
- (2013) L. Gatta et al. BMJ-British Medical Journal
- The effects of varying acidity onHelicobacter pylorigrowth and the bactericidal efficacy of ampicillin
- (2012) E. A. Marcus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- A new approach for elimination of gastric cancer deaths in Japan
- (2012) Masahiro Asaka INTERNATIONAL JOURNAL OF CANCER
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan
- (2011) Toshio Fujioka et al. JOURNAL OF GASTROENTEROLOGY
- Helicobacter pylorieradication therapy
- (2010) Hidekazu Suzuki et al. Future Microbiology
- Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition
- (2010) Masahiro Asaka et al. HELICOBACTER
- Helicobacter pyloriInfection
- (2010) Kenneth E.L. McColl NEW ENGLAND JOURNAL OF MEDICINE
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
- (2008) Kazutoshi Fukase et al. LANCET
- New concepts of resistance in the treatment of Helicobacter pylori infections
- (2008) David Y Graham et al. Nature clinical practice. Gastroenterology & hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now